Literature DB >> 998182

Diffusion of tranexamic acid to the joint.

A Ahlberg, O Eriksson, H Kjellman.   

Abstract

Tranexamic acid (Cyklokapron, Kabi, Stockholm) in a dose of 10 mg per kg body weight was given i.v. to 17 patients at various intervals before operation on the knee joint, in order to elucidate the diffusion of the drug to the joint fluid and the synovial membrane. The acid diffused rapidly to both the above tissues, and in the joint fluid it reached the same concentration as in the serum. The biologic half-time in the joint fluid was about 3 hours. In the treatment of joint bleedings in hemophiliacs and in association with intra-articular operations on such patients tranexamic acid is a suitable supplement to conventional substitution therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998182     DOI: 10.3109/17453677608988725

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  22 in total

1.  Tranexamic acid is toxic on human chondrocytes, in vitro.

Authors:  Benjamin Jacob; Nadja Kloss; Sabrina Böhle; Julia Kirschberg; Timo Zippelius; Markus Heinecke; Georg Matziolis; Eric Röhner
Journal:  J Orthop       Date:  2019-12-19

Review 2.  Clinical pharmacology of aminocaproic and tranexamic acids.

Authors:  I M Nilsson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

3.  Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.

Authors:  Chih-Hsiang Chang; Yuhan Chang; Dave W Chen; Steve W N Ueng; Mel S Lee
Journal:  Clin Orthop Relat Res       Date:  2014-01-03       Impact factor: 4.176

Review 4.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 5.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 6.  Toxicity of tranexamic acid (TXA) to intra-articular tissue in orthopaedic surgery: a scoping review.

Authors:  Scott M Bolam; Arama O'Regan-Brown; A Paul Monk; David S Musson; Jillian Cornish; Jacob T Munro
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-29       Impact factor: 4.342

Review 7.  Optimizing Intraoperative Blood Management for One-Stage Bilateral Total Knee Arthroplasty.

Authors:  Vasileios Soranoglou; Lazaros A Poultsides; Georgios K Triantafyllopoulos; Ivan De Martino; Stavros G Memtsoudis; Thomas P Sculco
Journal:  HSS J       Date:  2017-12-07

8.  Tranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial.

Authors:  Fernando Bidolegui; Guillermo Arce; Alfonso Lugones; Sebastián Pereira; Gabriel Vindver
Journal:  Open Orthop J       Date:  2014-07-11

Review 9.  Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.

Authors:  Yongcai Chen; Zhuo Chen; Shuo Cui; Zhiyang Li; Zhengjiang Yuan
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 10.  Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence.

Authors:  Christopher Kim; Sam Si-Hyeong Park; J Roderick Davey
Journal:  J Blood Med       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.